Advancing Medicine Through Cell and Gene Therapy

This panel discussion will cover advancements and challenges in cell and gene therapy (CGT), focusing on the implications for healthcare technology. Sanjay Srivastava, PhD, will share insights on the scientific and operational strategies needed to bring CGTs from concept to market, highlighting best practices in R&D, supply chain, and patient engagement. Stella Vnook, PhD, PharmD, MBA, will discuss the translational aspects of cell and gene therapy, emphasizing the journey from bench to bedside and critical factors for successful commercialization. Dalip Sethi, PhD, MBA, will speak to the technological advancements in cell processing and manufacturing, addressing how these innovations enhance cell-based therapies' scalability and efficacy. Matthieu de Kalbermatten, MSc, MBA, will offer insights into the strategic and operational challenges of bringing innovative therapies to global markets. Drawing on his track record of successfully growing businesses, Matthieu will discuss effective corporate strategies, partnerships, and market expansion tactics essential for advancing cell and gene therapies. Together, they will provide a holistic view of cell and gene therapy's current and future direction, offering healthcare professionals valuable knowledge.